265 related articles for article (PubMed ID: 9869513)
1. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].
Bouvet M; Bold RJ; Lee J; Evans DB; Abbruzzese JL; Chiao PJ; McConkey DJ; Chandra J; Chada S; Fang B; Roth JA
Ann Surg Oncol; 1998 Dec; 5(8):681-8. PubMed ID: 9869513
[TBL] [Abstract][Full Text] [Related]
2. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
4. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated gene transfer of a constitutively active retinoblastoma gene inhibits human pancreatic tumor cell proliferation.
Simeone DM; Cascarelli A; Logsdon CD
Surgery; 1997 Aug; 122(2):428-33; discussion 433-4. PubMed ID: 9288150
[TBL] [Abstract][Full Text] [Related]
6. E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells.
Elliott MJ; Farmer MR; Atienza C; Stilwell A; Dong YB; Yang HL; Wong SL; McMasters KM
Tumour Biol; 2002; 23(2):76-86. PubMed ID: 12065845
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
[TBL] [Abstract][Full Text] [Related]
8. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines.
Eisold S; Linnebacher M; Ryschich E; Antolovic D; Hinz U; Klar E; Schmidt J
World J Gastroenterol; 2004 Dec; 10(24):3583-9. PubMed ID: 15534911
[TBL] [Abstract][Full Text] [Related]
9. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-based p53 gene therapy in ovarian cancer.
Santoso JT; Tang DC; Lane SB; Hung J; Reed DJ; Muller CY; Carbone DP; Lucci JA; Miller DS; Mathis JM
Gynecol Oncol; 1995 Nov; 59(2):171-8. PubMed ID: 7590467
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene.
Hwang RF; Gordon EM; Anderson WF; Parekh D
Surgery; 1998 Aug; 124(2):143-50; discussion 150-1. PubMed ID: 9706132
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
Buttgereit P; Schakowski F; Märten A; Brand K; Renoth S; Ziske C; Schöttker B; Ebert O; Schroers R; Schmidt-Wolf IG
Cancer Gene Ther; 2001 Jun; 8(6):430-9. PubMed ID: 11498763
[TBL] [Abstract][Full Text] [Related]
14. Effect of an adenoviral vector that expresses the canine p53 gene on cell growth of canine osteosarcoma and mammary adenocarcinoma cell lines.
Yazawa M; Setoguchi A; Hong SH; Uyama R; Nakagawa T; Kanaya N; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2003 Jul; 64(7):880-8. PubMed ID: 12856773
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.
Katz MH; Spivack DE; Takimoto S; Fang B; Burton DW; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2003 Aug; 10(7):762-72. PubMed ID: 12900367
[TBL] [Abstract][Full Text] [Related]
16. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
[TBL] [Abstract][Full Text] [Related]
17. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.
Kleeff J; Fukahi K; Lopez ME; Friess H; Büchler MW; Sosnowski BA; Korc M
Cancer Gene Ther; 2002 Jun; 9(6):522-32. PubMed ID: 12032663
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.
Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP
Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791
[TBL] [Abstract][Full Text] [Related]
19. Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro.
Wu Q; Kreienberg R; Runnebaum IB
J Cancer Res Clin Oncol; 2000 Mar; 126(3):139-44. PubMed ID: 10741907
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
